Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites.

Geoffrey K. Isbister,Kalana Maduwage,Ana Saiao,Nicholas A. Buckley,Shaluka Jayamanne,Shahmy Seyed,Fahim Mohamed,Umesh Chathuranga,Alexandre Mendes,Chandana Abeysinghe,Harindra Karunathilake,Indika Gawarammana,David G. Lalloo,H. Janaka de Silva

Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites.

2015

Geoffrey K. Isbister
Kalana Maduwage
Ana Saiao
Nicholas A. Buckley
Shaluka Jayamanne
Shahmy Seyed
Fahim Mohamed
Umesh Chathuranga
Alexandre Mendes
Chandana Abeysinghe
Harindra Karunathilake
Indika Gawarammana
David G. Lalloo
H. Janaka de Silva

Background There is limited information on antivenom pharmacokinetics. This study aimed to investigate the pharmacokinetics of an Indian snake antivenom in humans with Russell’s viper bites.

Keywords:

Immunology
Traditional medicine
Veterinary medicine
Snake antivenom
VIPeR
Population
Russell's Viper
Pharmacokinetics
Medicine
Antivenom
population pharmacokinetics
pharmacokinetic analysis
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations